Skip to content
Screener

Medline, Inc. MDLN Q1 2026 earnings

Reported May 6, 2026 · Before market open

Revenue$7.4BBeat by $189.4M
EPS$0.33Beat by $0.03
Revenue estimate$7.2B
EPS estimate$0.30

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$7.7B
EPS estimate$0.34

Financials

Q1 2026

Income statement

See full
Revenue$7.4B+10.7%
Gross profit$1.8B+0.9%
Operating income$422.0M-26.1%
Net income$239.0M-25.1%
EPS (diluted)$0.16—

Balance sheet

See full
Cash & equivalents$2.2B+166%
Total debt$12.6B—
Total equity$11.3B—
Total assets$39.0B—

Cash flow

See full
Operating cash flow$412.0M-39.6%
CapEx$96.0M-2.0%
Free cash flow$316.0M-45.9%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$36.12B—
Enterprise value$46.44B—
P/E33.5×—

Returns & leverage

See full
Debt / equity1.1×—
Current ratio4.4×—

Segments

By product

See full
Front Line Care$1.6B+6.0%
Surgical Solutions$1.6B+7.4%
Laboratory and Diagnostics$293.0M+0.7%

By segment

See full
Supply Chain Solutions$3.9B+15.0%
Medline Brand$3.5B+6.2%

By geography

See full
International$495.0M+10.0%

Versus estimates

Revenue

Q2 2026$7.7BBeat by $166.2M
Q1 2026$7.4BBeat by $189.4M
Q4 2025$7.8BBeat by $274.8MQ3 2025$7.1B

Diluted EPS

Q2 2026$0.50Beat by $0.15
Q1 2026$0.33Beat by $0.03
Q4 2025$0.22Miss by $0.02Q3 2025$0.31

FAQ

When did Medline, Inc. report Q1 2026 earnings?
Medline, Inc. (MDLN) reported Q1 2026 earnings on May 6, 2026 before market open.
What were Medline, Inc.'s Q1 2026 revenue and EPS?
Medline, Inc. reported revenue of $7.4B and eps of $0.33 for Q1 2026.
Did Medline, Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $7.2B by $189.4M. EPS beat the consensus estimate of $0.30 by $0.03.
Where can I find Medline, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0002046386-26-000022) and the 10-Q periodic report (0002046386-26-000026) directly on SEC EDGAR. The filing index links above go to sec.gov.